期刊
SEMINARS IN IMMUNOPATHOLOGY
卷 33, 期 2, 页码 129-134出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00281-011-0257-9
关键词
Lung transplantation; Obliterative bronchiolitis; Bronchiolitis obliterans syndrome; Alloimmunity; Autoimmunity; IL-17; T cells; Rejection
资金
- National Institute of Health [K08 AI059105]
- American Society of Transplantation [RO1 HL60797]
In the past decade, advances in immunology have led to the recognition that T cell differentiation is not simply Th1 or Th2 but involves differentiation to other subsets, such as T regulatory cells, T follicular helper cells, and Th17 cells. Th17 cells, characterized by production of IL-17, IL-22, and IL-21, have been implicated in the pathogenesis of autoimmune diseases, like rheumatoid arthritis and multiple sclerosis, but also play an important role in host defense and mucosal immunity. IL-17, with its pleiotropic effects on stromal cells, as well as hematopoietic cells, has long been recognized as a possible mediator of rejection after lung transplantation. Recent data have implicated IL-17 and Th17 cells in the development of autoimmunity and chronic rejection after lung transplantation in both animal models and humans. In this review, we will discuss the current data on Th17 and the prospects for the future for lung transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据